Dahlia Biosciences
Dahlia Biosciences offers premium RNA Flow Assays designed for researchers and scientists in the life sciences industry.
About Dahlia Biosciences
Discover our range of products and solutions today.
Dahlia Biosciences is a company based in San Francisco, United States. Recent Funding lists it under Health and bio. It went through IndieBio (IndieBio SF 06). Investors on record for it include SOSV and SOSV SF & NY (Fka IndieBio). It was founded by Un Kwon, Brad Taft, Michael Lin and 1 other.
Funding rounds
- IndieBio SF 06
IIndieBio · batchSource: indiebio.co - Website created
Founders and team
UK
Un Kwon Co-Founder & CEOsource: dahliabio.comBT
Brad Taft Co-Founder & CSOsource: dahliabio.comML
Michael Lin FounderSS
Samuel Sternberg Founder
Investors
Similar Health and bio companies
HHexagon Bio$62M Series B+ · Oct 2026
BBioStack$9.5M Seed · Oct 2026HHeyVoli$500K Pre Seed · Oct 2026
VVitalls$1.5M Seed · Oct 2026
WWarp Sciences$215M Series A · Oct 2026
PPAM2L Biotechnologies$29.97M Series A · Oct 2026
Questions and sources
Dahlia Biosciences: questions and answers
- Who invested in Dahlia Biosciences?
- Investors on record for Dahlia Biosciences: IndieBio, SOSV and SOSV SF & NY (Fka IndieBio).
- Who founded Dahlia Biosciences?
- Dahlia Biosciences was founded by Un Kwon (Co-Founder & CEO), Brad Taft (Co-Founder & CSO), Michael Lin and Samuel Sternberg.
- Where is Dahlia Biosciences based?
- Dahlia Biosciences is based in San Francisco, United States.
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/dahlia-biosciences (get a free API key).